Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A generalized epilepsy with febrile seizures plus that has material basis in heterozygous mutation in SCN1B on chromosome 19q13.11.
Features include: Bilateral tonic-clonic seizure, Febrile seizure (within the age range of 3 months to 6 years), Generalized non-motor (absence) seizure, and Atonic seizure.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 4 | Bilateral tonic-clonic seizure, Febrile seizure (within the age range of 3 months to 6 years), Generalized non-motor (absence) seizure |
SCN1B function has not been fully characterized.
Generalized epilepsy with febrile seizures plus, type 1 is associated with mutations in the SCN1B gene on chromosome 19.
Genetic testing for SCN1B is available. Testing is considered confirmatory for diagnosis.
No clinical trials have been registered for generalized epilepsy with febrile seizures plus, type 1.
1 publication has been identified in PubMed for generalized epilepsy with febrile seizures plus, type 1. Research spans Review / Meta-Analysis (100%).
De Sainte Agathe JM (2025). [PMID: 39729883](https://pubmed.ncbi.nlm.nih.gov/39729883/). *EBioMedicine*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 1:33 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center